NGM BIOPHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFWarrant Agreement • June 5th, 2020 • NGM Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 5th, 2020 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between NGM BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
NGM BIOPHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • June 5th, 2020 • NGM Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 5th, 2020 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between NGM BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
OPEN MARKET SALE AGREEMENTSMNGM Biopharmaceuticals Inc • June 5th, 2020 • Pharmaceutical preparations • New York
Company FiledJune 5th, 2020 Industry Jurisdiction